{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:29:02Z","timestamp":1768454942483,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41440-023-01243-9","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T08:03:50Z","timestamp":1678262630000},"page":"1673-1683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The associations of adipokines with hypertension in youth with cardiometabolic risk and the mediation role of insulin resistance: The BCAMS study"],"prefix":"10.1038","volume":"46","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"1243_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration.","year":"2021","unstructured":"NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet (Lond, Engl). 2021;398:957\u201380.","journal-title":"Lancet (Lond, Engl)"},{"key":"1243_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/HYPERTENSIONAHA.121.17300","volume":"78","author":"K Liu","year":"2021","unstructured":"Liu K, Li C, Gong H, Guo Y, Hou B, Chen L, et al. Prevalence and risk factors for hypertension in adolescents aged 12 to 17 years: A school-based study in China. Hypertension (Dallas, Tex: 1979). 2021;78:1577\u201385.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"1243_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","volume":"15","author":"JE Hall","year":"2019","unstructured":"Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: Mechanistic links. Nat Rev Nephrol. 2019;15:367\u201385.","journal-title":"Nat Rev Nephrol"},{"key":"1243_CR4","doi-asserted-by":"publisher","unstructured":"Vliora M, Ravelli C, Grillo E, Corsini M, Flouris AD, Mitola S. The impact of adipokines on vascular networks in adipose tissue. Cytokine & growth factor reviews (e-pub ahead of print 23 July 2022; https:\/\/doi.org\/10.1016\/j.cytogfr.2022.07.008).","DOI":"10.1016\/j.cytogfr.2022.07.008)"},{"key":"1243_CR5","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1161\/CIRCULATIONAHA.107.741645","volume":"117","author":"KK Koh","year":"2008","unstructured":"Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008;117:3238\u201349.","journal-title":"Circulation"},{"key":"1243_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/HYPERTENSIONAHA.109.148213","volume":"56","author":"A Shankar","year":"2010","unstructured":"Shankar A, Xiao J. Positive relationship between plasma leptin level and hypertension. Hypertension (Dallas, Tex: 1979).2010;56:623\u20138.","journal-title":"Hypertension (Dallas, Tex: 1979)."},{"key":"1243_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ajh.2009.244","volume":"23","author":"C Asferg","year":"2010","unstructured":"Asferg C, M\u00f8gelvang R, Flyvbjerg A, Frystyk J, Jensen JS, Marott JL, et al. Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. Am J Hypertens. 2010;23:327\u201333.","journal-title":"Am J Hypertens"},{"key":"1243_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/10641963.2018.1557684","volume":"42","author":"MM Ghaedian","year":"2020","unstructured":"Ghaedian MM, Nazari Jaz A, Momeni M, Ghaedian T, Samiei N. Plasma leptin level is positively associated with blood pressure measures independent of gender and BMI. Clin Exp Hypertens. (NY: 1993). 2020;42:31\u20135.","journal-title":"Clin Exp Hypertens. (NY: 1993)"},{"key":"1243_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.120.16174","volume":"77","author":"AD Kaze","year":"2021","unstructured":"Kaze AD, Musani SK, Bidulescu A, Correa A, Bertoni AG, Ahima RS, et al. Plasma leptin and blood pressure progression in blacks: The Jackson heart study. Hypertension (Dallas, Tex: 1979). 2021;77:1069\u201375.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"1243_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/HYPERTENSIONAHA.120.14513","volume":"77","author":"V Oliveira","year":"2021","unstructured":"Oliveira V, Kwitek AE, Sigmund CD, Morselli LL, Grobe JL. Recent Advances in hypertension: Intersection of metabolic and blood pressure regulatory circuits in the central nervous system. Hypertension (Dallas, Tex: 1979). 2021;77:1061\u20138.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"1243_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941\u20136.","journal-title":"Nat Med"},{"key":"1243_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/oby.2008.564","volume":"17","author":"A Onat","year":"2009","unstructured":"Onat A, Hergen\u00e7 G, Can G, K\u00fc\u00e7\u00fckdurmaz Z. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men. Obes (Silver Spring, Md). 2009;17:564\u201370.","journal-title":"Obes (Silver Spring, Md)"},{"key":"1243_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1291\/hypres.31.229","volume":"31","author":"T Imatoh","year":"2008","unstructured":"Imatoh T, Miyazaki M, Momose Y, Tanihara S, Une H. Adiponectin levels associated with the development of hypertension: a prospective study. Hypertens Res: Off J Jpn Soc Hypertens. 2008;31:229\u201333.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1243_CR14","doi-asserted-by":"publisher","unstructured":"Peri-Okonny PA, Ayers C, Maalouf N, Das SR, de Lemos JA, Berry JD, et al. Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study. Diabetes\/Metabol Res Rev. 2017;33. https:\/\/doi.org\/10.1002\/dmrr.2840.","DOI":"10.1002\/dmrr.2840"},{"key":"1243_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/ajh\/hpab101","volume":"34","author":"AD Kaze","year":"2021","unstructured":"Kaze AD, Musani SK, Bidulescu A, Correa A, Golden SH, Bertoni AG, et al. Plasma Adiponectin and blood pressure progression in African Americans: The Jackson heart study. Am J Hypertens. 2021;34:1163\u201370.","journal-title":"Am J Hypertens"},{"key":"1243_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Q Yang","year":"2005","unstructured":"Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356\u201362.","journal-title":"Nature"},{"key":"1243_CR17","doi-asserted-by":"publisher","first-page":"111312","DOI":"10.1016\/j.mce.2021.111312","volume":"531","author":"PA Nono Nankam","year":"2021","unstructured":"Nono Nankam PA, Bl\u00fcher M. Retinol-binding protein 4 in obesity and metabolic dysfunctions. Mol Cell Endocrinol. 2021;531:111312.","journal-title":"Mol Cell Endocrinol"},{"key":"1243_CR18","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2337\/dc06-0360","volume":"29","author":"YM Cho","year":"2006","unstructured":"Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 2006;29:2457\u201361.","journal-title":"Diabetes Care"},{"key":"1243_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","volume":"6","author":"N Kl\u00f6ting","year":"2007","unstructured":"Kl\u00f6ting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 2007;6:79\u201387.","journal-title":"Cell Metab"},{"key":"1243_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5:415\u201325.","journal-title":"Cell Metab"},{"key":"1243_CR21","doi-asserted-by":"publisher","first-page":"254s","DOI":"10.3945\/ajcn.2009.28449B","volume":"91","author":"SA Kliewer","year":"2010","unstructured":"Kliewer SA, Mangelsdorf DJ. Fibroblast growth factor 21: From pharmacology to physiology. Am J Clin Nutr. 2010;91:254s\u20137s.","journal-title":"Am J Clin Nutr"},{"key":"1243_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","volume":"27","author":"X Pan","year":"2018","unstructured":"Pan X, Shao Y, Wu F, Wang Y, Xiong R, Zheng J, et al. FGF21 prevents Angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2\/Angiotensin-(1-7) Axis in Mice. Cell Metab. 2018;27:1323\u201337.e5.","journal-title":"Cell Metab"},{"key":"1243_CR23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1210\/jc.2015-3760","volume":"101","author":"L Li","year":"2016","unstructured":"Li L, Yin J, Cheng H, Wang Y, Gao S, Li M, et al. Identification of genetic and environmental factors predicting metabolically healthy obesity in children: Data from the BCAMS study. J Clin Endocrinol Metab. 2016;101:1816\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"1243_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ebiom.2018.05.033","volume":"32","author":"G Li","year":"2018","unstructured":"Li G, Feng D, Wang Y, Fu J, Han L, Li L, et al. Loss of cardio-protective effects at the CDH13 locus due to gene-sleep interaction: The BCAMS study. EBioMedicine 2018;32:164\u201371.","journal-title":"EBioMedicine"},{"key":"1243_CR25","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.clnu.2018.08.039","volume":"38","author":"J Fu","year":"2019","unstructured":"Fu J, Han L, Zhao Y, Li G, Zhu Y, Li Y, et al. Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: The BCAMS study. Clin Nutr (Edinb, Scotl). 2019;38:2161\u20137.","journal-title":"Clin Nutr (Edinb, Scotl)"},{"key":"1243_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ijo.2009.44","volume":"33","author":"M Li","year":"2009","unstructured":"Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes. (2005). 2009;33:424\u201339.","journal-title":"Int J Obes. (2005)"},{"key":"1243_CR27","first-page":"3293","volume":"88","author":"M Li","year":"2008","unstructured":"Li M, Yin JH, Zhang K, Wu CY. [A highly sensitive enzyme-linked immunosorbent assay for measurement of leptin secretion in human adipocytes]. Zhonghua yi xue za zhi. 2008;88:3293\u20137.","journal-title":"Zhonghua yi xue za zhi"},{"key":"1243_CR28","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.metabol.2012.06.001","volume":"61","author":"Q Li","year":"2012","unstructured":"Li Q, Lu Y, Sun L, Yan J, Yan X, Fang L, et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease. Metab: Clin Exp. 2012;61:1803\u20138.","journal-title":"Metab: Clin Exp"},{"key":"1243_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-016-0461-y","volume":"15","author":"J Fu","year":"2016","unstructured":"Fu J, Hou C, Li L, Feng D, Li G, Li M, et al. Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome. Cardiovasc Diabetol. 2016;15:142.","journal-title":"Cardiovasc Diabetol"},{"key":"1243_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0707-y","volume":"17","author":"G Li","year":"2018","unstructured":"Li G, Esangbedo IC, Xu L, Fu J, Li L, Feng D, et al. Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study. Cardiovasc. Diabetol. 2018;17:69.","journal-title":"Cardiovasc. Diabetol"},{"key":"1243_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"1243_CR32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/CIRCULATIONAHA.115.017936","volume":"133","author":"B Xi","year":"2016","unstructured":"Xi B, Zong X, Kelishadi R, Hong YM, Khadilkar A, Steffen LM, et al. Establishing International Blood Pressure References Among Nonoverweight Children and Adolescents Aged 6 to 17 Years. Circulation 2016;133:398\u2013408.","journal-title":"Circulation"},{"key":"1243_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-01963-0","volume":"19","author":"R Philip","year":"2021","unstructured":"Philip R, Beaney T, Appelbaum N, Gonzalvez CR, Koldeweij C, Golestaneh AK, et al. Variation in hypertension clinical practice guidelines: a global comparison. BMC Med. 2021;19:117.","journal-title":"BMC Med"},{"key":"1243_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/03637751.2017.1352100","volume":"85","author":"AF Hayes","year":"2018","unstructured":"Hayes AF. Partial, conditional, and moderated moderated mediation: Quantification, inference, and interpretation. Commun Monogr. 2018;85:4\u201340.","journal-title":"Commun Monogr"},{"key":"1243_CR35","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/aje\/kwq332","volume":"172","author":"TJ Vanderweele","year":"2010","unstructured":"Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010;172:1339\u201348.","journal-title":"Am J Epidemiol"},{"key":"1243_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","volume":"58","author":"DP MacKinnon","year":"2007","unstructured":"MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593\u2013614.","journal-title":"Annu Rev Psychol"},{"key":"1243_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tins.2013.01.004","volume":"36","author":"SE Simonds","year":"2013","unstructured":"Simonds SE, Cowley MA. Hypertension in obesity: is leptin the culprit? Trends Neurosci. 2013;36:121\u201332.","journal-title":"Trends Neurosci"},{"key":"1243_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13679-016-0231-x","volume":"5","author":"BB Bell","year":"2016","unstructured":"Bell BB, Rahmouni K. Leptin as a Mediator of Obesity-Induced Hypertension. Curr Obes Rep. 2016;5:397\u2013404.","journal-title":"Curr Obes Rep"},{"key":"1243_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41569-020-00437-9","volume":"18","author":"PL Valenzuela","year":"2021","unstructured":"Valenzuela PL, Carrera-Bastos P, G\u00e1lvez BG, Ruiz-Hurtado G, Ordovas JM, Ruilope LM, et al. Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol. 2021;18:251\u201375.","journal-title":"Nat Rev Cardiol"},{"key":"1243_CR40","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.2337\/dc11-0118","volume":"34","author":"C Meisinger","year":"2011","unstructured":"Meisinger C, R\u00fcckert IM, Rathmann W, D\u00f6ring A, Thorand B, Huth C, et al. Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes care. 2011;34:1648\u201350.","journal-title":"Diabetes care"},{"key":"1243_CR41","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1210\/jc.2007-1219","volume":"92","author":"Q Qi","year":"2007","unstructured":"Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab. 2007;92:4827\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"1243_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0121-z","volume":"13","author":"V Lambadiari","year":"2014","unstructured":"Lambadiari V, Kadoglou NP, Stasinos V, Maratou E, Antoniadis A, Kolokathis F, et al. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol. 2014;13:121.","journal-title":"Cardiovasc Diabetol"},{"key":"1243_CR43","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ajh.2009.116","volume":"22","author":"A Solini","year":"2009","unstructured":"Solini A, Santini E, Madec S, Rossi C, Muscelli E. Retinol-binding protein-4 in women with untreated essential hypertension. Am J Hypertens. 2009;22:1001\u20136.","journal-title":"Am J Hypertens"},{"key":"1243_CR44","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/jhh.2017.44","volume":"31","author":"JX Zhang","year":"2017","unstructured":"Zhang JX, Zhu GP, Zhang BL, Cheng YY. Elevated serum retinol-binding protein 4 levels are correlated with blood pressure in prehypertensive Chinese. J Hum Hypertens. 2017;31:611\u20135.","journal-title":"J Hum Hypertens"},{"key":"1243_CR45","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.2337\/dc09-0684","volume":"32","author":"AO Chavez","year":"2009","unstructured":"Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care. 2009;32:1542\u20136.","journal-title":"Diabetes Care"},{"key":"1243_CR46","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, et al. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 2010;59:2781\u20139.","journal-title":"Diabetes"},{"key":"1243_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/jhh.2012.52","volume":"27","author":"RD Semba","year":"2013","unstructured":"Semba RD, Crasto C, Strait J, Sun K, Schaumberg DA, Ferrucci L. Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults. J Hum Hypertens. 2013;27:397\u20139.","journal-title":"J Hum Hypertens"},{"key":"1243_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep29582","volume":"6","author":"JL He","year":"2016","unstructured":"He JL, Zhao M, Xia JJ, Guan J, Liu Y, Wang LQ, et al. FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats. Sci Rep. 2016;6:29582.","journal-title":"Sci Rep"},{"key":"1243_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.metabol.2012.02.005","volume":"61","author":"UI Khan","year":"2012","unstructured":"Khan UI, Wang D, Sowers MR, Mancuso P, Everson-Rose SA, Scherer PE, et al. Race-ethnic differences in adipokine levels: the Study of Women\u2019s Health Across the Nation (SWAN). Metab: Clin Exp. 2012;61:1261\u20139.","journal-title":"Metab: Clin Exp"},{"key":"1243_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation.","year":"2004","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (Lond, Engl). 2004;363:157\u201363.","journal-title":"Lancet (Lond, Engl)"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01243-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01243-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01243-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T23:04:21Z","timestamp":1688511861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01243-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01243-9","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"assertion":[{"value":"6 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Peking Union Medical College Hospital. Written informed consent to participate in this study was provided by the participants\u2019 legal guardian\/next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}